Anti-TFPI for hemostasis induction in patients with rare bleeding disorders, an ex vivo thrombin generation (TG) guided pilot study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-TFPI for hemostasis induction in patients with rare bleeding disorders, an ex vivo thrombin generation (TG) guided pilot study

Published:2022-07 Issue: Volume:95 Page:102663
ISSN:1079-9796
Container-title:Blood Cells, Molecules, and Diseases
language:en
Short-container-title:Blood Cells, Molecules, and Diseases

Author:

Barg Assaf A.,Brutman-Barazani Tami,Avishai Einat,Budnik Ivan,Cohen Omri,Dardik Rima,Levy-Mendelovich Sarina,Livnat Tami,Kenet Gili

Publisher

Elsevier BV

Subject

Cell Biology,Hematology,Molecular Biology,Molecular Medicine

Reference30 articles.

1. Rare bleeding disorders-old diseases in the era of novel options for therapy;Livnat;Blood Cells Mol. Dis.,2017

2. Treatment of rare factor deficiencies other than hemophilia;Menegatti;Blood,2019

3. Regulation of tissue factor initiated thrombingeneration by the stoichiometric inhibitors tissue factor pathway in-hibitor, antithrombin III, and heparin cofactor II;Van't Veer;J. Biol. Chem.,1997

4. Biology of tissue factor pathway inhibitor;Wood;Blood,2014

5. Tissue factor pathway inhibitor: multiple anticoagulant activities for a single protein;Mast;Arterioscler. Thromb. Vasc. Biol.,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factor XI deficiency: phenotypic age-related considerations and clinical approach towards bleeding risk assessment;Blood;2024-04-11

2. Molecular and clinical characterization of two unrelated families with factor V deficiency, including a novel nonsense variant (p.Gln1532*);Blood Cells, Molecules, and Diseases;2024-01

3. Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency;Journal of Thrombosis and Haemostasis;2023-03

4. Beyond uterine atony: characterizing postpartum hemorrhage coagulopathy;American Journal of Obstetrics & Gynecology MFM;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3